PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Ethanol extract of flower buds attenuated cigarette smoke-induced lung inflammation in mice [PMID: 34601084]
Tussilagone showed anti-tumor effects on proliferation, EMT, and metastasis in cell lines and in vivo [PMID: 41029481]
n-hexane and ethyl acetate extracts displayed antitubercular activity against Mycobacterium tuberculosis H37Rv in vitro [PMID: 24955560]
A hydrogel containing T. farfara and ZnO nanoparticles facilitated wound healing and showed antibacterial activity against S. aureus in a rat model [PMID: 41066935]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 33069788 (2021) — A review of the ethnobotanical value, phytochemistry, pharmacology, toxicity and quality control of Tussilago farfara L. (coltsfoot). · Journal of ethnopharmacology
- 2.PMID: 35356793 (2022) — The complete chloroplast genome sequence of Tussilago farfara (Asteraceae). · Mitochondrial DNA. Part B, Resources
- 3.PMID: 40892112 (2025) — Coltsfoot (Tussilago farfara L.; Asteraceae): modern methods of extraction, phytochemistry, nanoparticles synthesis, ethnopharmacology, and biological activities. · Natural product research
- 4.PMID: 32105669 (2020) — A systematic review and quality assessment of case reports of adverse events for borage (Borago officinalis), coltsfoot (Tussilago farfara) and comfrey (Symphytum officinale). · Fitoterapia
- 5.PMID: 27867270